Another example of a pre-clinical company getting bought for nearly $1B. This company was bought for it's technology or platform if you will. This is what I believe to be the value of CVBT, the technology used to create lifesaving drugs. AS pipelines dry up, companies like CVBT will be bought to offer hope in creating new drugs and beefing up the pipeline of large pharma. Just need the legal obstacles to get cleared up first.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.